StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
VANI

Vivani Medical, Inc.

VANI Nasdaq Electromedical & Electrotherapeutic Apparatus EDGAR ↗
$1.33
+0.03 +2.31%

Key statistics

from XBRL data in SEC filings
Market cap
$115M
Revenue (TTM)
$0.00
Net income (TTM)
$26.1M
EPS (TTM)
$-0.40
P/E ratio
Dividend yield
Free cash flow
-$25.5M
Cash
$19.7M
Total assets
$42.4M
Gross margin
52-week range
$0.92 – $1.92

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Regulation FD disclosure Jul 16, 2026 8-K Entered a material agreement; Other events Jul 7, 2026 8-K Director or officer change; Shareholder vote results; Other events Jun 30, 2026 8-K Regulation FD disclosure Jun 4, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 13, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) Mar 26, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jan 27, 2026 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 13, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Oct 28, 2025 8-K Regulation FD disclosure; Other events Oct 3, 2025 8-K Other events Sep 17, 2025 8-K Regulation FD disclosure Sep 9, 2025 8-K Other events Sep 4, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Regulation FD disclosure; Other events Aug 13, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Aug 5, 2025 8-K Shareholder vote results Jun 25, 2025 8-K Regulation FD disclosure Jun 17, 2025 8-K Director or officer change; Regulation FD disclosure Jun 11, 2025 8-K Other events May 29, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Regulation FD disclosure; Other events May 13, 2025 8-K Other events Apr 15, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 31, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Mar 27, 2025 8-K Other events Mar 26, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Mar 13, 2025 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 13, 2024 8-K Other events Oct 22, 2024 8-K Other events Sep 26, 2024 8-K Other events Sep 23, 2024 8-K Other events Sep 4, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 13, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Other events Jul 11, 2024